CIMAX | LGMCX | CIMAX / LGMCX | |
Total Expense Ratio | 0.61 | 1.91 | 32% |
Annual Report Gross Expense Ratio | 0.61 | 1.91 | 32% |
Fund Existence | 24 years | 20 years | - |
Gain YTD | 12.172 | 6.961 | 175% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 136B | 2.88B | 4,722% |
Annual Yield % from dividends | 3.67 | 0.29 | 1,285% |
Returns for 1 year | 11.86 | 1.61 | 738% |
Returns for 3 years | 23.62 | 7.27 | 325% |
Returns for 5 years | 43.37 | -3.57 | -1,216% |
Returns for 10 years | 75.84 | 27.54 | 275% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TGBLX | 11.09 | 0.04 | +0.36% |
T. Rowe Price Global Impact Equity I | |||
TEMUX | 15.99 | 0.03 | +0.19% |
Morgan Stanley Pathway Em Mkts Eq | |||
FDSSX | 87.04 | -0.30 | -0.34% |
Fidelity Stock Selec | |||
FZIPX | 14.30 | -0.06 | -0.42% |
Fidelity ZERO Extended Market Index | |||
CEIZX | 14.00 | -0.07 | -0.50% |
Manning & Napier Callodine Equity Inc Z |